Yahoo Web Search

Search results

    • Avidity Biosciences (NASDAQ:RNA) PT Raised to $45.00

      ETF DAILY NEWS· 6 hours ago

      The brokerage presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC reaffirmed a “buy” rating and set a $35.00 price objective on shares of Avidity Biosciences ...